Increased rate of tumor cell death caused by polyamine synthesis inhibitors

Virchows Archiv. B, Cell Pathology Including Molecular Pathology
|January 1, 1984
PubMed

Insights

Polyamine synthesis inhibitors increase tumor cell death. Methylglyoxal-bis(guanylhydrazone) is more potent than DL-alpha-difluoromethylornithine in reducing tumor cell proliferation and survival.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Polyamines are essential for cell growth and proliferation.
  • Inhibiting polyamine synthesis is a potential anti-cancer strategy.
  • The role of cell death in the antiproliferative effects of these inhibitors requires elucidation.

Purpose of the Study:

  • To determine if cell death contributes to the antiproliferative effects of polyamine synthesis inhibitors.
  • To quantify tumor cell death induced by specific polyamine synthesis inhibitors.
  • To compare the potency of DL-alpha-difluoromethylornithine and methylglyoxal-bis(guanylhydrazone) in inducing tumor cell death.

Main Methods:

  • In vivo studies using mice with Ehrlich ascites tumor cells labeled with 5-125I-iodo-2'-deoxyuridine to measure 125I excretion as an indicator of cell death.
  • In vitro studies culturing Ehrlich ascites tumor cells in suspension and treating them with inhibitors.
  • Assessing tumor cell death through growth kinetics and colony-forming efficiency assays.

Main Results:

  • Both DL-alpha-difluoromethylornithine (ornithine decarboxylase inhibitor) and methylglyoxal-bis(guanylhydrazone) (S-adenosylmethionine decarboxylase inhibitor) increased 125I excretion, indicating enhanced tumor cell death in vivo.
  • Methylglyoxal-bis(guanylhydrazone) demonstrated greater potency in increasing tumor cell death compared to DL-alpha-difluoromethylornithine.
  • In vitro studies confirmed that these inhibitors not only slow tumor cell growth but also significantly increase tumor cell death.

Conclusions:

  • Polyamine synthesis inhibitors demonstrably induce tumor cell death, contributing to their antiproliferative action.
  • Methylglyoxal-bis(guanylhydrazone) is a more potent inducer of tumor cell death than DL-alpha-difluoromethylornithine.
  • These findings support the therapeutic potential of polyamine synthesis inhibitors in cancer treatment by promoting tumor cell death.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...